RxDoctor Payments Data

Hollie Mills

Family Medicine · Coeur D Alene, IDNPI 1871905562

Payments from drug & device makers

$933in general payments, 2019–2025

Across 18 payments — averaging $51.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$340
  • Ascendis Pharma Endocrinology Inc$179
  • Boston Scientific$147
  • AbbVie$71
  • Kyowa Kirin, Inc.$60
  • Abbott$34
  • plus $101 from 4 others

What the payments were for

  • Food & beverage$933100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$933 in reported general payments places this provider in the 70th percentile of 803 family medicine providers in Idaho.

See all family medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$95,477
Medicare patients
170
Services billed
1,532

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide27$39,958
JardianceEmpagliflozin13$16,895
EliquisApixaban16$16,890
Repatha SureclickEvolocumab16$12,169
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$10,308
VeozahFezolinetant11$5,795
ShingrixVaricella-Zoster Ge/As01b/Pf21$4,598
Rosuvastatin Calcium244$3,848
Fluticasone-SalmeterolFluticasone Propion/Salmeterol30$3,313
Gabapentin47$1,540
Scopolamine12$1,525
Levothyroxine Sodium154$1,471
Atorvastatin Calcium142$1,365
Losartan Potassium144$1,188
Buspirone Hcl21$1,123

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSynthroid$71$1,06019 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 803 family medicine providers in Idaho.

Other family medicine in Coeur D Alene

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →